Preclinical/translational tools and strategies

CELL AND GENE THERAPY INSIGHTS

February 2021

Preclinical/translational tools and strategies

Download PDF

Foreword

Preclinical/translational tools & strategies

Preclinical/translational tools & strategies

Bruce A Bunnell

24 February 2021

Editorial

Accelerating preclinical development for AAV based gene therapies: bridging the gap between discovery and clinical development

Accelerating preclinical development for AAV based gene therapies: bridging the gap between discovery and clinical development

Louise Rodino-Klapac

24 February 2021

Expert Insight

Modelling late-onset diseases with induced pluripotent stem cells: a matter of time management

Modelling late-onset diseases with induced pluripotent stem cells: a matter of time management

Charlotte Cossins, Paul J Fairchild

15 February 2021

The T cell therapy field faces preclinical and translational R&D challenges as it targets more complex diseases

The T cell therapy field faces preclinical and translational R&D challenges as it targets more complex diseases

G Waanders, S Raffegerst, P Prinz-Schulz et al.

15 February 2021

Animal models of disease: preclinical to clinical gene therapy translatability

Animal models of disease: preclinical to clinical gene therapy translatability

Erika Matsumoto Plata, Carlos R Plata-Salamán

11 February 2021

Commentary

Expediting novel ex vivo HSC gene therapies to the clinic: a preclinical perspective

Expediting novel ex vivo HSC gene therapies to the clinic: a preclinical perspective

G Leoni, A Lambert, C Hudson et al.

24 February 2021

FastFacts

Identify and select optimal T cell phenotypes

Identify and select optimal T cell phenotypes

22 February 2021

Podcast

On a mission to bring single-cell sequencing to cell and gene therapy

On a mission to bring single-cell sequencing to cell and gene therapy

24 February 2021

Interview

On a mission to bring single-cell sequencing to cell and gene therapy

On a mission to bring single-cell sequencing to cell and gene therapy

24 February 2021

Beginning gene therapy preclinical development with the end in mind: from preclinical to economic modelling

Beginning gene therapy preclinical development with the end in mind: from preclinical to economic modelling

Olivier Negre, PhD

16 February 2021